Tandem Diabetes Care (NSDQ:TNDM) announced today that it appointed Dr. Jordan Pinsker as its VP & medical director.
The San Diego-based insulin delivery technology developer’s appointment of Pinsker will be made effective on April 26, 2021, according to a news release.
Pinsker joins Tandem from Sansum Diabetes Research Institute in Santa Barbara, Calif., where he served as Director of Artificial Pancreas Technology starting in 2018. While with Sansum, he served as a lead investigator in a number of clinical trials for automated insulin delivery systems, including Tandem’s Basal-IQ and Control-IQ technology.
He also served as Chief of Pediatric Endocrinology at Tripler Army Medical Center in Hawaii, along with a role as a physician in the U.S. Army in both active duty and the California Army National Guard for more than 20 years.
“Dr. Pinsker brings extensive knowledge in patient care, diabetes epidemiology, and physician practice efficiency, in addition to sharing our passion for improving the lives of people with diabetes,” Tandem Diabetes Care president & CEO John Sheridan said in the release. “We welcome him to Tandem’s management team as we work together to lead in insulin therapy management using our automated insulin delivery technology and flagship pumps.”